Increasing demand for home care nutritional products and increasing demand to meet cancer patient’s nutritional requirements are the major factors driving oncology nutritional market growth.

Market Size – USD 1.52 Billion in 2018, Market Growth - CAGR of 8.2%, Market Trends –Increasing demand for home care nutritional products and increasing demand to meet cancer patient’s nutritional requirements.

NEW YORK, May 06, 2019 (GLOBE NEWSWIRE) -- The Oncology Nutrition Market is forecast to grow from USD 1.52 Billion in 2018 to USD 2.77 Billion by 2026, at a CAGR of 8.2%, during the forecast period. The market is primarily driven by the increasing demand for home care nutritional products and increasing demand to meet cancer patient’s nutritional requirements.                                                       

Dietary factors are identified as having a significant impact on cancer risk, with different dietary elements increasing as well as reducing risk. Diet and obesity can be associated with up to 30% to 35% of deaths from cancer, whereas physical inactivity appears to be associated with 7% cancer risk.

Request free sample of this research report at: https://www.reportsanddata.com/sample-enquiry-form/1374

About 85% of all cases of cancer are caused by diet and lifestyle. Food is vital. It can contribute to cancer development as well as help the cancer process prevention and management. Clinical outcomes are significantly improved by using Oncology Nutrition as an integrated and holistic approach to cancer.

Overall market growth is driven largely by shifting focus from parenteral to enteral nutrition, increasing cancer incidence, increasing demand for nutritional requirements in the home care sector, increasing number of patients being treated for malnutrition, and increasing the quality of nutritional interventions in clinical research.

Further key findings from the report suggest

• The Oncology Nutrition Market is forecasted to grow from USD 1.52 Billion in 2018 to USD 2.77 Billion by 2026, at a CAGR of 8.2%, during the forecast period. The market is primarily driven by the increasing demand for home care nutritional products and increasing demand to meet cancer patient’s nutritional requirements.
• Based on cancer type, the market is segmented into breast, liver, stomach & gastrointestinal, head & neck, pancreatic, esophageal, lung, blood and other cancers. The head & neck segment is expected to hold the largest market share throughout the forecast period. It is expected to reach USD 560.5 Million in 2026, at a CAGR of 9.7% during the forecast period.
• Based on distribution channel, the market is segmented into hospitals, online pharmacies and retail pharmacies. The hospital is expected to hold the largest market share during the forecast period. It is expected to reach USD 1.06 Billion in 2026, at a CAGR of 8.5% during the forecast period.

To identify the key trends in the industry, click on the link below:   https://www.reportsanddata.com/report-detail/oncology-nutrition-market

• Based on nutrition support, the market is segmented into enteral nutrition and parenteral nutrition. The enteral nutrition market is expected to hold the largest market share throughout the forecast period. It is expected to grow at a CAGR of 8.3% during the forecast period.
• Based on region, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa and Latin America. The North America region is expected to hold the largest market share throughout the forecast period. It is expected to reach USD 1.01 Billion in 2026, at a CAGR of 8.6% during the forecast period. North America is showing significant market growth due to the increasing prevalence of chronic diseases and disorders, coupled with the rapidly growing aging population, showing greater susceptibility to chronic and acute disorders than other segments of the population.
• The major players in the market are Hormel Foods (US), Fresenius Kabi AG (Germany), Meiji Holdings (Japan), Nestle S.A. (Switzerland), Mead Johnson Nutrition Company (US), Abbott Laboratories (US), Danone (France), B. Braun Melsungen AG (Germany), Victus (US), Global Health Products (US) and others.

Order Now: https://www.reportsanddata.com/checkout-form/1374

Segments covered in the report:

This report forecasts volume and revenue growth at a global, regional & country level, and provides an analysis on the industry trends in each of the sub-segments from 2016 to 2026. For the purpose of this study, Reports and Data have segmented the market on the basis of type, stages, distribution channel, nutrition support end use and regional analysis:                      

Type (Revenue, USD Million; 2016-2026)

• Stomach and Gastrointestinal Cancers
• Liver Cancer
• Breast Cancer
• Lung Cancer
• Esophageal Cancer
• Head and Neck Cancer
• Pancreatic Cancer
• Blood Cancer
• Other Cancers

End User (Revenue, USD Million; 2016-2026)

• Hospitals
• Clinics

Distribution Channel (Revenue, USD Million; 2016-2026)

• Hospitals
• Retail Pharmacies
• Online Pharmacies

Stages (Revenue, USD Million; 2016-2026)

• Chemotherapy
• Hormone therapy
• Radiation therapy
• Surgery
• Immunotherapy
• Stem cell transplant

Nutrition Support (Revenue, USD Million; 2016-2026)

• Enteral Nutrition
• Parenteral Nutrition

Regional Outlook (Volume, Kilo Tons; Revenue, USD Billion; 2018-2026)

• North America
  • U.S.
• Europe
  • UK
  • France
• Asia Pacific
  • China
  • India
  • Japan
• MEA
• Latin America
  • Brazil

Browse more reports of Pharmaceutical category at:  https://www.reportsanddata.com/report/category/pharma-and-healthcare

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John Watson
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-800-819-3052
E-mail: sales@reportsanddata.com